NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotechnology’

14 January 2015

New Leaf, Apposite to exit biotech company Convergence to trade partner

four-leaf-clovers-1381213-m The venture capital backers of UK biotechnology company Convergence Pharmaceuticals have reportedly agreed to sell their stakes to Nasdaq-listed Biogen Idec for $675m.

13 January 2015

Qualcomm Ventures forms $100m investment partnership with Novartis

syringe-974378-m Qualcomm Ventures, the venture capital arm of Qualcomm Incorporated, has partnered with Novartis Pharmaceuticals to target early stage companies in the healthcare tech sector.

9 January 2015

Ally Bridge leads $25m Series B round in Hua Medicine

drug-pharma-medical-healthcare Clinical-stage biotechnology company Hua Medicine has closed a $25m Series B financing led by private equity firm Ally Bridge Group.

18 December 2014

Atlas drives $23m Series A round for biotech company

padlock Atlas Ventures has invested the biggest chunk of cash in a $23m funding round for biotechnology company Padlock Therapeutics.

1 December 2014

Growth hormone deficiency treatment company Ascendis picks up $60m VC-backed Series D

drug tablet pill medical pharma Sofinnova Ventures has joined with OrbiMed and Vivo Capital to lead a $60m Series D financing round for biotech business Ascendis Pharma.

25 November 2014

VC-backed biotech company Promethera pulls in €20m Series C

download (2) Venture capital backed Belgian biotechnology company Promethera Biosciences has raised €20.3m in Series C funding with investors including the Belgian Federal Holding and Investment Company.

24 November 2014

Gimv makes 4.6x return selling stake in biotech company BioMarin

test-tubes-1-1416029-m European investment house Gimv has made an impressive 4.6-times return multiple selling its stake in genetic disorder treatment company business Prosensa to BioMarin

15 October 2014

Biotech sees September private equity, venture capital dealmaking slumpp

biotech virus lab Private equity and venture capital dealmaking in the global biotechnology sector suffered a sharp slump in value in September to $180m, new research has shown.

3 October 2014

Forbion holds €92m first close for third healthcare fund

health Netherlands-based private equity firm Forbion Capital Partners has held a €92m first close for its third fund focused on emerging healthcare businesses.

3 October 2014

Merck, Vertex and Temasek lead $30m round in Visterra

Visterra Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek have co-led a $30m Series B financing round in biotechnology company Visterra.

Page 1 of 912345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015